Yaya Yu

No. 111, Dade Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types.

Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types.

Journal: Experimental hematology & oncology

Published: October 06, 2025

Huang-qin decoction increases the sensitivity of EGFR-TKIs to NSCLC cells by regulating stat3/GPX4 to induce redox ratio and ROS to inhibit CSCs.

Huang-qin decoction increases the sensitivity of EGFR-TKIs to NSCLC cells by regulating stat3/GPX4 to induce redox ratio and ROS to inhibit CSCs.

Journal: Journal of traditional and complementary medicine

Published: August 06, 2024

Unraveling impact and potential mechanisms of baseline pain on efficacy of immunotherapy in lung cancer patients: a retrospective and bioinformatic analysis.

Unraveling impact and potential mechanisms of baseline pain on efficacy of immunotherapy in lung cancer patients: a retrospective and bioinformatic analysis.

Journal: Frontiers in immunology

Published: June 28, 2024

Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments.

Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 11, 2024

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells.

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells.

Journal: BMC cancer

Published: May 05, 2023

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers.

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers.

Journal: Frontiers in immunology

Published: June 08, 2022

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway.

Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway.

Journal: Molecular carcinogenesis

Published: August 19, 2021

Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer.

Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer.

Journal: OncoTargets and therapy

Published: June 29, 2019

The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells.

The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells.

Journal: Frontiers in oncology

Published: June 18, 2019

The emerging roles of PIWI-interacting RNA in human cancers.

The emerging roles of PIWI-interacting RNA in human cancers.

Journal: Cancer management and research

Published: March 21, 2019

Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.

Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus.

Journal: Nature communications

Published: May 31, 2017

Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer.

Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer.

Journal: Oncology letters

Published: December 16, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026